GSK sued Moderna for infringement of US patent rights for COVID and RSV vaccines
British drugmaker GlaxoSmithKline sued Moderna in a US federal court in Delaware, accusing the company of infringing GSK’s patent rights to GSK’s information RNA technology with its most popular COVID-19 vaccine Spikevax and RSV vaccine mResvia.
ENTRADAS POPULARES
IEA warns ‘electricity era’ will come after fossil fuels peak
octubre 17, 2024
Easter Island fights global plastic waste vortex
octubre 17, 2024
Egypt opens more galleries at its antiquities museum
octubre 17, 2024
TRANSMISIÓN EN VIVO